HomeCompareADGCF vs MRK

ADGCF vs MRK: Dividend Comparison 2026

ADGCF yields 28985.51% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADGCF wins by $2.097158067946092e+21M in total portfolio value
10 years
ADGCF
ADGCF
● Live price
28985.51%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.097158067946092e+21M
Annual income
$2,083,021,285,333,056,000,000,000,000.00
Full ADGCF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ADGCF vs MRK

📍 ADGCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADGCFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADGCF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADGCF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADGCF
Annual income on $10K today (after 15% tax)
$2,463,768.12/yr
After 10yr DRIP, annual income (after tax)
$1,770,568,092,533,097,600,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ADGCF beats the other by $1,770,568,092,533,097,600,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADGCF + MRK for your $10,000?

ADGCF: 50%MRK: 50%
100% MRK50/50100% ADGCF
Portfolio after 10yr
$1.048579033973046e+21M
Annual income
$1,041,510,642,666,528,000,000,000,000.00/yr
Blended yield
99.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ADGCF
No analyst data
Altman Z
-33.2
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADGCF buys
0
MRK buys
0
No recent congressional trades found for ADGCF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADGCFMRK
Forward yield28985.51%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$2.097158067946092e+21M$56.8K
Annual income after 10y$2,083,021,285,333,056,000,000,000,000.00$9,798.13
Total dividends collected$2.0962277539050705e+21M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ADGCF vs MRK ($10,000, DRIP)

YearADGCF PortfolioADGCF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$2,909,251$2,898,550.72$11,206$366.19+$2.90MADGCF
2$791,207,365$788,094,466.92$12,650$502.35+$791.19MADGCF
3$201,157,071,550$200,310,479,668.76$14,407$694.19+$201157.06MADGCF
4$47,810,626,596,255$47,595,388,529,697.21$16,585$967.82+$47810626.58MADGCF
5$10,623,475,664,740,646$10,572,318,294,282,652.00$19,342$1,363.89+$10623475664.72MADGCF
6$2,206,842,865,929,723,100$2,195,475,746,968,450,600.00$22,913$1,947.19+$2206842865929.70MADGCF
7$428,596,853,141,100,400,000$426,235,531,274,555,600,000.00$27,662$2,823.89+$428596853141100.44MADGCF
8$77,823,404,333,199,590,000,000$77,364,805,700,338,600,000,000.00$34,159$4,173.35+$77823404333199584.00MADGCF
9$13,211,946,367,323,016,000,000,000$13,128,675,324,686,495,000,000,000.00$43,337$6,308.80+$13211946367323015168.00MADGCF
10$2,097,158,067,946,092,000,000,000,000$2,083,021,285,333,056,000,000,000,000.00$56,776$9,798.13+$2.097158067946092e+21MADGCF

ADGCF vs MRK: Complete Analysis 2026

ADGCFStock

Advance Lithium Corp., an exploration stage company, engages in the exploration and evaluation of mineral property interests in Canada, Kenya, and Mexico. It explores for lithium, precious metals, and fertilizer minerals. The company has 13 lithium, -potassiumboron, and boron salars in Central Mexico. It also holds a 100% interest in the Tabasquena silver mine and Venaditas polymetalic project in Zacatecas, Mexico; and a 9.78% interest in the Kakamega advanced gold project in Kenya. The company was formerly known as Advance Gold Corp. and changed its name to Advance Lithium Corp. in December 2021. Advance Lithium Corp. was incorporated in 2004 and is headquartered in Kamloops, Canada.

Full ADGCF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ADGCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADGCF vs SCHDADGCF vs JEPIADGCF vs OADGCF vs KOADGCF vs MAINADGCF vs JNJADGCF vs ABBVADGCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.